CD19 has emerged as a potential target for monoclonal antibody therapy
which consists of an N-terminal immunoglobulin variable region-like (IgV) domain containing approximately 100 amino acids and a serine/threonine-rich mucinoid domain of varying lengths containing target sites for O- and N- binding glycosylation
The chemokine CCL22
HBV Surface Antigen-preS2 is also an effective regulator of apoptosis induced by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)
Expression System HEK293 Molecular Weight 48-80kDa Purity >95% by SDS-PAGE Endotoxin <0
IL-6 Protein, Mouse Size:10μg CD19 has emerged as aProduct Specification Species Mouse Synonyms Interleukin 6 protein, IL 6 protein; Interleukin 6, IL 6, B Cell Hybridoma Growth Factor, Interleukin HP 1, Il6, Il 6 Accession P08505 Amino Acid Sequence Phe25 Thr211 Expression System E. coli Molecular Weight 22kDa Purity 95% by SDS PAGE&RP HPLC Endotoxin <0. 1EU g Conjugation Unconjugated Tag No Tag Physical Appearance Lyophilized Powder Storage Buffer 1x PBS, pH 7. 4 Reconstitution Reconstitute at 0. 1